Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesLaboratory/PathologyModa Health Salivary Testing Coverage | OpenPayer
    Ask Trek AI about this page
    CurrentModa HealthPolicy HCS-0060

    Salivary Hormone Testing

    Customize your policy alerts

    Sign up for Moda Health Policy HCS-0060 alerts

    Get alerted when Policy HCS-0060 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs Moda Health coverage and prior authorization requirements for salivary hormone testing. Coverage is limited to testing requested to evaluate suspected hypercortisolism associated with Cushing's syndrome in children and adults, subject to ordering, laboratory, documentation, and indication requirements.

    Policy Summary
    PayerModa Health
    PolicySalivary Hormone Testing
    Policy CodePolicy HCS-0060
    Change TypeNo material change
    Effective DateOct 1, 2026
    Last ReviewSep 23, 2026
    Next Review DateN/A
    Key ActionSubmit chart notes indicating suspicion of hypercortisolism with the prior authorization request.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    1Covered indication
    3Requirements
    17Not-covered codes

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    3Covered codes
    5Diagnosis codes

    Coverage Criteria

    Covered salivary hormone testing

    Salivary hormone testing is considered medically necessary if ALL of the following criteria are met.

    Medical necessity criteria

    • Covered clinical use: The test is requested to evaluate suspected hypercortisolism of Cushing's syndrome in children and adults.
    • Qualified ordering professional: The test is ordered by a qualified health professional.
    • Laboratory requirement: The test is performed in a CLIA-approved laboratory.

      Clinical Laboratory Improvement Amendments-approved laboratory.

    • Indication exclusion: The test is not requested for diagnosis or monitoring of menopause, diagnosis or monitoring of diseases related to aging such as osteoporosis, or any other indication not mentioned in the policy.

    Testing requested for diagnosis or monitoring of menopause, diseases related to aging such as osteoporosis, or any other indication not mentioned in the policy is excluded from coverage.

    Salivary hormone testing is not medically necessary when it is not requested to evaluate suspected hypercortisolism of Cushing's syndrome in children or adults.

    Covered Indications

    Evaluation of suspected hypercortisolism of Cushing's syndrome in children and adults

    Covered when used to evaluate suspected hypercortisolism of Cushing's syndrome.

    Covered indication

    • Screening test: Late-night salivary cortisol is used as a screening test for Cushing's syndrome.

    Coding and Diagnosis Codes

    CPT or HCPCS codes coveredCPTCovered
    82530Cortisol; free [other than late-night salivary cortisol for diagnosing Cushing's syndrome]
    82533Cortisol; total [other than late-night salivary cortisol for diagnosing Cushing's syndrome]
    84999Unlisted chemistry procedure
    CPT or HCPCS codes NOT covered for salivary hormone testingCPTNot Covered
    82626Dehydroepiandrosterone (DHEA)
    82627Dehydroepiandrosterone-sulfate (DHEA-S)
    82670Estradiol
    82671Estrogens; fractionated
    82672Estrogens; total
    82677Estriol
    82679Estrone
    83516Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; qualitative or semiquantitative, multiple step method [salivary testing for anti-tissue transglutaminase for the diagnosis of celiac disease]
    83520Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; quantitative, not otherwise specified [not covered for measurement of salivary level of interleukin-8 as biomarkers for oral pre-cancer and oral squamous cell carcinoma] [not covered for salivary antibody testing (IgA, IgG, IgM) for the diagnosis of Sicca syndrome]
    84144Progesterone
    1–10 of 20
    1/2
    CPT or HCPCS codes NOT covered for salivary hormone testingHCPCSNot Covered
    88341Immunohistochemistry or immunocytochemistry, per specimen; each additional single antibody stain procedure
    88342Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain
    S3650Saliva test, hormone level; during menopause
    Applicable Diagnosis CodesICD-10
    E24.0Pituitary-dependent Cushing's disease
    E24.2Drug-induced Cushing's syndrome
    E24.3Ectopic ACTH syndrome
    E24.8Other Cushing's syndrome
    E24.9Cushing's syndrome, unspecified

    Prior Authorization and Provider Requirements

    Prior Authorization

    Prior Authorization Required for Covered Testing

    Prior authorization is required for covered salivary hormone testing. The request must include the required clinical documentation and demonstrate that all medical-necessity criteria are satisfied.

    • Covered testing must be requested to evaluate suspected hypercortisolism of Cushing's syndrome in children or adults.
    • The request must identify a qualified health professional as the ordering professional and a CLIA-approved laboratory where the test will be performed.
    • The request must not involve an excluded indication listed below.
    Documentation Required

    Required Clinical Documentation

    Submit chart notes with the prior authorization request. The notes must indicate suspicion of hypercortisolism.

    • Required documentation: chart notes indicating suspicion of hypercortisolism.

    Background

    Salivary hormone testing is promoted as a noninvasive method for measuring hormones, including progesterone, estrogen, testosterone, melatonin, and DHEA. The policy identifies late-night salivary cortisol testing as a screening method for Cushing's syndrome, a disorder caused by prolonged exposure to elevated cortisol.

    Definitions

    Cushing's syndrome
    DefinitionA hormonal disorder caused by prolonged exposure of the body's tissues to high levels of cortisol hormone.
    Associated hormoneCortisol.
    Diagnostic contextCushing's syndrome can be diagnosed by measuring excessive cortisol levels.
    Late-night salivary cortisol
    DefinitionA salivary cortisol measurement performed late at night.
    UseA simple way to screen for Cushing's syndrome.
    RationaleCortisol levels vary throughout the day but drop considerably during the night.

    Ordering Requirements

    Note

    Use a qualified ordering professional

    The test must be ordered by a qualified health professional.

    Not Covered Services

    The following uses are not covered: salivary hormone testing for diagnosis or monitoring of menopause; diagnosis or monitoring of diseases related to aging, including osteoporosis; and any other indication not mentioned in the policy.

    Policy Summary
    PayerModa Health
    PolicySalivary Hormone Testing
    Policy CodePolicy HCS-0060
    Change TypeNo material change
    Effective DateOct 1, 2026
    Last ReviewSep 23, 2026
    Next Review DateN/A
    Key ActionSubmit chart notes indicating suspicion of hypercortisolism with the prior authorization request.
    SourceLink
    On This Page
    Coverage CriteriaCovered IndicationsCoding and Diagnosis CodesPrior Authorization and Provider RequirementsBackgroundDefinitionsOrdering RequirementsNot Covered Services
    Note

    Core Medical Necessity Requirements

    Salivary hormone testing is medically necessary only when all core requirements are met.

    • The test is requested to evaluate suspected hypercortisolism of Cushing's syndrome in children or adults.
    • The test is ordered by a qualified health professional.
    • The test is performed in a CLIA (Clinical Laboratory Improvement Amendments)-approved laboratory.
    • The request is not for an excluded indication.
    Denial Risk

    Excluded Indications

    Testing is not medically necessary when requested for the following indications.

    • Diagnosis and/or monitoring of menopause.
    • Diagnosis and/or monitoring of diseases related to aging, including osteoporosis.
    • Any other indication not specifically mentioned as covered.
    Billing Rule

    Non-Covered Procedure Codes

    The following CPT or HCPCS codes are not covered for salivary hormone testing.

    • 82626 — Dehydroepiandrosterone (DHEA).
    • 82627 — Dehydroepiandrosterone-sulfate (DHEA-S).
    • 82670 — Estradiol.
    • 82671 — Estrogens; fractionated.
    • 82672 — Estrogens; total.
    • 82677 — Estriol.
    • 82679 — Estrone.
    • 83516 — Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; qualitative or semiquantitative, multiple-step method; includes salivary testing for anti-tissue transglutaminase for diagnosis of celiac disease.
    • 83520 — Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; quantitative, not otherwise specified; includes salivary measurement of interleukin-8 as a biomarker for oral precancer and oral squamous cell carcinoma and salivary antibody testing (IgA, IgG, IgM) for diagnosis of Sicca syndrome.
    • 84144 — Progesterone.
    • 84402 — Testosterone; free.
    • 84403 — Testosterone; total.
    • 84436 — Thyroxine; total.
    • 84437 — Thyroxine; total, requiring elution (e.g., neonatal).
    • 84439 — Thyroxine; free, requiring elution (e.g., neonatal).
    • 84443 — Thyroid stimulating hormone (TSH).
    • 84479 — Thyroid hormone (T3 or T4) uptake or thyroid hormone binding ratio (THBR).
    • 84480 — Triiodothyronine (T3); total (TT-3).
    • 84481 — Triiodothyronine (T3); free.
    • 86316 — Immunoassay for tumor antigen or other antigen, quantitative (e.g., CA 50, CA 72-4, CA 549), each; includes salivary measurement of CYFRA 21-1 as a biomarker for oral precancer and oral squamous cell carcinoma.
    • 88341 — Immunohistochemistry or immunocytochemistry, per specimen; each additional single antibody stain procedure (list separately in addition to code for primary procedure).
    • 88342 — Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain.
    • S3650 — Saliva test, hormone level; during menopause.
    CLIA-approved laboratory
    DefinitionA laboratory approved under the Clinical Laboratory Improvement Amendments (CLIA).
    RequirementThe test must be performed in a CLIA-approved laboratory.
    Applicable testingThis laboratory requirement applies to salivary hormone testing.